Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C

Liver International

Volumn 26, Issue 9, 2006, Pages 1100-1110

  He, Qi ^a   Graham, Camilla S ^a   Mangoni, Emanuele Durante ^a   Koziel, Margaret James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hepatitis C virus; Nuclear factor of activated T cells; Sustained virologic response; T helper (Th)1 2 cytokines; Toll like receptors

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; NUCLEAR FACTOR; PEGINTERFERON ALPHA2A; RIBAVIRIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CELL COUNT; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON TYPE II; INTERFERON-GAMMA; MALE; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; POLYETHYLENE GLYCOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS; TREATMENT OUTCOME;

EID: 33749633453     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01357.x     Document Type: Article

References (54)

1. Nelson D R, Marousis C G, Ohno T, Davis G L, Lau J Y. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 1998; 28: 225-30.
2. Cramp M E, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov N V. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000; 118: 346-55.
3. Kamal S M, Fehr J, Roesler B, Peters T, Rasenack J W. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002; 123: 1070-83.
4. Fearon D T, Locksley R M. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
5. Lemaitre B. The road to Toll. Nat Rev Immunol 2004; 4: 521-7.
6. Zarember K A, Godowski P J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554-61.
7. Yoshimura A, Lien E, Ingalls R R, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
8. Opitz B, Schroder N W, Spreitzer I, et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 2001; 276: 22041-7.
9. Alexopoulou L, Holt A C, Medzhitov R, Flavell R A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-8.
10. Poltorak A, Smirnova I, He X, et al. Genetic and physical mapping of the Lps locus: Identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998; 24: 340-55.
11. Gewirtz A T, Navas T A, Lyons S, Godowski P J, Madara J L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-5.
12. Takeuchi O, Kawai T, Muhlradt P F, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13: 933-40.
13. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-9.
14. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-5.
15. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
16. Medzhitov R, Janeway C Jr. Innate immune recognition: Mechanisms and pathways. Immunol Rev 2000; 173: 89-97.
17. Rao A, Luo C, Hogan P G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15: 707-47.
18. Northrop J P, Ho S N, Chen L, et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994; 369: 497-502.
19. Serfling E, Berberich-Siebelt F, Chuvpilo S, et al. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta 2000; 1498: 1-18.
20. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-7.
21. Boehme K W, Compton T. Innate sensing of viruses by toll-like receptors. J Virol 2004; 78: 7867-73.
22. Bowie A G, Haga I R. The role of Toll-like receptors in the host response to viruses. Mol Immunol 2005; 42: 859-67.
23. Pavio N, Lai M M. The hepatitis C virus persistence: How to evade the immune system? J Biosci 2003; 28: 287-304.
24. Andre P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919-28.
25. Pumeechockchai W, Bevitt D, Agarwal K, et al. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. J Med Virol 2002; 68: 335-42.
26. Sing A, Rost D, Tvardovskaia N, et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002; 196: 1017-24.
27. Dolganiuc A, Oak S, Kodys K, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004; 127: 1513-24.
28. Doyle S E, O'Connell R, Vaidya S A, Chow E K, Yee K, Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol 2003; 170: 3565-71.
29. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003; 300: 1145-8.
30. Machida K, Cheng K T, Sung V M, Levine A M, Foung S, Lai M M. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006; 80: 866-74.
31. Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman D M, Ishii K J. Transcriptional regulation of the human TLR9 gene. J Immunol 2004; 173: 2552-61.
32. Fukuda K, Tsuchihara K, Hijikata M, Nishiguchi S, Kuroki T, Shimotohno K. Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology 2001; 33: 159-65.
33. Li W, Whaley C D, Bonnevier J L, et al. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation. J Immunol 2001; 167: 827-35.
34. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 2006; 12: 1198-204.
35. Hertz C J, Kiertscher S M, Godowski P J, et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001; 166: 2444-50.
36. Brightbill H D, Libraty D H, Krutzik S R, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732-6.
37. Thoma-Uszynski S, Kiertscher S M, Ochoa M T, et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 2000; 165: 3804-10.
38. Xu D, Komai-Koma M, Liew F Y. Expression and function of Toll-like receptor on T cells. Cell Immunol 2005; 233: 85-89.
39. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-50.
40. Reis e Sousa C. Toll-like receptors and dendritic cells: For whom the bug tolls. Semin Immunol 2004; 16: 27-34.
41. Miettinen M, Sareneva T, Julkunen I, Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2001; 2: 349-55.
42. Geiss G K, Carter V S, He Y, et al. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003; 77: 6367-75.
43. Siren J, Pirhonen J, Julkunen I, Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 2005; 174: 1932-7.
44. Frese M, Schwarzle V, Barth K, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002; 35: 694-703.
45. Liu C, Zhu H, Tu Z, Xu Y L, Nelson D R. CD8+ T-cell interaction with HCV replicon cells: Evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 2003; 37: 1335-42.
46. Pawlotsky J M. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003; 59: 1-11.
47. Liew F Y, Xu D, Brint E K, O'Neill L A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-58.
48. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-95.
49. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197: 403-11.
50. Crellin N K, Garcia R V, Hadisfar O, Allan S E, Steiner T S, Levings M K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+ CD25+ T regulatory cells. J Immunol 2005; 175: 8051-9.
51. Moseman E A, Liang X, Dawson A J, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25+ regulatory T cells. J Immunol 2004; 173: 4433-42.
52. Hertzog P J, O'Neill L A, Hamilton J A. The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003; 24: 534-9.
53. Bode J G, Ludwig S, Ehrhardt C, et al. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 2003; 17: 488-90.
54. Vlotides G, Sorensen A S, Kopp F, et al. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 2004; 320: 1007-14.